5 research outputs found
Herb Sector in Greece: Training Needs and Perspectives
The Greek flora is rich in native herbaceous plants and due to the Mediterranean climate, there are optimal climatic and soil conditions for their cultivation. Herbs play a very important role in the Greek rural economy and facilitate change in the national agro-food sector as it is still developing. In recent years, this sector has become an area of interest. Many farmers changed their old crops into new cultivations like herbs. This development requires investments, training programs, new studies, and projects in order to enrich the knowledge and skills of all the participants involved in the value chain. HEGO is a Black Sea Project, funded by the European Union, and one of its main goals is the modernization of enterprises associated with the cultivation, production, and promotion of diversified, sustainable, value-added herb products, as well as the enhancement of cross-border trade opportunities for local herb enterprises in participating Black Sea Basin countries (Greece, Moldova, Georgia, and Armenia). This paper explores the current situation of the herb sector in Greece regarding the cultivation, processing legislation, managerial issues, and the trade value of herb products. More specifically, its purpose is to investigate the current skills and expertise in herbs of the participants in Greece. Additionally, this paper explores the future training needs in relation to the above mention topics. Descriptive statistics, SWOT, and PEST analysis were performed. The main results of this research revealed the lack of knowledge of wildcrafting practices and trading. The importance of further training was highlighted, especially in marketing and trading skills. These findings can be used to develop training curricula and courses in order to cope with potential threats in the herb sector in Greece.
Keywords: herbs, Greece, training needs, skills, knowledg
Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the pediatric oncology east and mediterranean (POEM) group
Background: Childhood cancer is a highly curable disease when timely diagnosis and appropriate therapy are provided. A negative impact of the coronavirus disease 2019 (COVID-19) pandemic on access to care for children with cancer is likely but has not been evaluated.Methods: A 34-item survey focusing on barriers to pediatric oncology management during the COVID-19 pandemic was distributed to heads of pediatric oncology units within the Pediatric Oncology East and Mediterranean (POEM) collaborative group, from the Middle East, North Africa, and West Asia. Responses were collected on April 11 through 22, 2020. Corresponding rates of proven COVID-19 cases and deaths were retrieved from the World Health Organization database.Results: In total, 34 centers from 19 countries participated. Almost all centers applied guidelines to optimize resource utilization and safety, including delaying off-treatment visits, rotating and reducing staff, and implementing social distancing, hand hygiene measures, and personal protective equipment use. Essential treatments, including chemotherapy, surgery, and radiation therapy, were delayed in 29% to 44% of centers, and 24% of centers restricted acceptance of new patients. Clinical care delivery was reported as negatively affected in 28% of centers. Greater than 70% of centers reported shortages in blood products, and 47% to 62% reported interruptions in surgery and radiation as well as medication shortages. However, bed availability was affected in \u3c30% of centers, reflecting the low rates of COVID-19 hospitalizations in the corresponding countries at the time of the survey.Conclusions: Mechanisms to approach childhood cancer treatment delivery during crises need to be re-evaluated, because treatment interruptions and delays are expected to affect patient outcomes in this otherwise largely curable disease
Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia Region: A report from the Pediatric Oncology East and Mediterranean (POEM) Group
Background Childhood cancer is a highly curable disease when timely
diagnosis and appropriate therapy are provided. A negative impact of the
coronavirus disease 2019 (COVID-19) pandemic on access to care for
children with cancer is likely but has not been evaluated. METHODS A
34-item survey focusing on barriers to pediatric oncology management
during the COVID-19 pandemic was distributed to heads of pediatric
oncology units within the Pediatric Oncology East and Mediterranean
(POEM) collaborative group, from the Middle East, North Africa, and West
Asia. Responses were collected on April 11 through 22, 2020.
Corresponding rates of proven COVID-19 cases and deaths were retrieved
from the World Health Organization database. Results In total, 34
centers from 19 countries participated. Almost all centers applied
guidelines to optimize resource utilization and safety, including
delaying off-treatment visits, rotating and reducing staff, and
implementing social distancing, hand hygiene measures, and personal
protective equipment use. Essential treatments, including chemotherapy,
surgery, and radiation therapy, were delayed in 29\% to 44\% of centers,
and 24\% of centers restricted acceptance of new patients. Clinical care
delivery was reported as negatively affected in 28\% of centers. Greater
than 70\% of centers reported shortages in blood products, and 47\% to
62\% reported interruptions in surgery and radiation as well as
medication shortages. However, bed availability was affected in <30\% of
centers, reflecting the low rates of COVID-19 hospitalizations in the
corresponding countries at the time of the survey. Conclusions
Mechanisms to approach childhood cancer treatment delivery during crises
need to be re-evaluated, because treatment interruptions and delays are
expected to affect patient outcomes in this otherwise largely curable
disease
Study of energy response and resolution of the ATLAS Tile Calorimeter to hadrons of energies from 16 to 30 GeV
International audienceThree spare modules of the ATLAS Tile Calorimeter were exposed to test beams from the Super Proton Synchrotron accelerator at CERN in 2017. The detector’s measurements of the energy response and resolution to positive pions and kaons, and protons with energies ranging from 16 to 30 GeV are reported. The results have uncertainties of a few percent. They were compared to the predictions of the Geant4-based simulation program used in ATLAS to estimate the response of the detector to proton-proton events at the Large Hadron Collider. The determinations obtained using experimental and simulated data agree within the uncertainties
Study of energy response and resolution of the ATLAS Tile Calorimeter to hadrons of energies from 16 to 30 GeV
Three spare modules of the ATLAS Tile Calorimeter were exposed to test
beams from the Super Proton Synchrotron accelerator at CERN in 2017. The
detector's measurements of the energy response and resolution to
positive pions and kaons, and protons with energies ranging from 16 to
30 GeV are reported. The results have uncertainties of a few percent.
They were compared to the predictions of the Geant4-based simulation
program used in ATLAS to estimate the response of the detector to
proton-proton events at the Large Hadron Collider. The determinations
obtained using experimental and simulated data agree within the
uncertainties